The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
Abstract
Multidrug-resistant tuberculosis (MDR) is perceived as a growing hazard to human health worldwide. Judgments about the true scale of the problem, and strategies for containing it, need to come from a balanced appraisal of the epidemiological evidence. We conclude in this review that MDR is, and will probably remain, a locally severe problem; that epidemics can be prevented by fully exploiting the potential of standard short-course chemotherapy (SCC) based on cheap and safe first-line drugs; and that best-practice SCC may even reduce the incidence of MDR where it has already become endemic. On the basis of the available, imperfect data, we recommend a three-part response to the threat of MDR: widespread implementation of SCC as the cornerstone of good tuberculosis control, improved resistance testing and surveillance, and the careful introduction of second-line drugs after a sound evaluation of cost, effectiveness, and feasibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Global Trends in Resistance to Antituberculosis Drugs
Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., Hoffner, S., Rieder, H. L., Binkin, N., Dye, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441706 · Cited by 671
Self-citationEspinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Self-citationThe intrinsic transmission dynamics of tuberculosis epidemics
Blower, S. M., Mclean, A. R., Porco, T. C., Small, P. M., Hopewell, P. C., Sanchez, M. A., & Moss, A. R. (1995) · Nature Medicine · doi:10.1038/nm0895-815 · Cited by 471
Control Strategies for Tuberculosis Epidemics: New Models for Old Problems
Blower, S. M., Small, P. M., & Hopewell, P. C. (1996) · Science · doi:10.1126/science.273.5274.497 · Cited by 350
Van Soolingen, D. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00772.x · Cited by 350
Cohn, D. L., Bustreo, F., & Raviglione, M. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s121 · Cited by 340
Self-citationVernon, A., Burman, W., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 308
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.276.15.1229 · Cited by 295
Molecular Epidemiology of Tuberculosis in the Netherlands: A Nationwide Study from 1993 through 1997
van Soolingen, D., Borgdorff, M. W., de Haas, P. E. W., Sebek, M. M. G. G., Veen, J., Dessens, M., Kremer, K., & van Embden, J. D. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/314930 · Cited by 285
Cited by
Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., Jensen, P., & Bayona, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60410-2 · Cited by 1,018
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017863 · Cited by 805
“In the early 2000s, it was believed that resistance mutations conferred a loss of fitness, so the transmission of resistant strains would be selflimited (Dye et al. 2002; Cegielski 2010).”
BackgroundImmune Control of Tuberculosis by IFN-γ-Inducible LRG-47
MacMicking, J. D., Taylor, G. A., & McKinney, J. D. (2003) · Science · doi:10.1126/science.1088063 · Cited by 685
The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis
Gagneux, S., Long, C. D., Small, P. M., Van, T., Schoolnik, G. K., & Bohannan, B. J. M. (2006) · Science · doi:10.1126/science.1124410 · Cited by 627
Ecology and evolution of Mycobacterium tuberculosis
Gagneux, S. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.8 · Cited by 599
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Evolution and transmission of drug-resistant tuberculosis in a Russian population
Casali, N., Nikolayevskyy, V., Balabanova, Y., Harris, S. R., Ignatyeva, O., Kontsevaya, I., Corander, J., Bryant, J., Parkhill, J., Nejentsev, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2878 · Cited by 473
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives
Gygli, S. M., Borrell, S., Trauner, A., & Gagneux, S. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux011 · Cited by 457
Boshoff, H. I. M., Reed, M. B., Barry, C. E., & Mizrahi, V. (2003) · Cell · doi:10.1016/s0092-8674(03)00270-8 · Cited by 421
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Falzon, D., Schünemann, H. J., Harausz, E., González-Angulo, L., Lienhardt, C., Jaramillo, E., & Weyer, K. (2017) · European Respiratory Journal · doi:10.1183/13993003.02308-2016 · Cited by 420
Molecular Epidemiology of Tuberculosis: Current Insights
Mathema, B., Kurepina, N. E., Bifani, P. J., & Kreiswirth, B. N. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-05 · Cited by 413
Fremond, C. M., Togbe, D., Doz, E., Rose, S., Vasseur, V., Maillet, I., Jacobs, M., Ryffel, B., & Quesniaux, V. F. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1178 · Cited by 338
The global situation of MDR-TB
Espinal, M. A. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00058-6 · Cited by 329
Self-citationFatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88
Fremond, C. M., Yeremeev, V., Nicolle, D. M., Jacobs, M., Quesniaux, V. F., & Ryffel, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421027 · Cited by 318
Kana, B. D., Gordhan, B. G., Downing, K. J., Sung, N., Vostroktunova, G., Machowski, E. E., Tsenova, L., Young, M., Kaprelyants, A., Kaplan, G., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.06078.x · Cited by 295
Antimicrobial resistance in developing countries. Part II: strategies for containment
Okeke, I. N., Klugman, K. P., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Laxminarayan, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70217-6 · Cited by 290
Resuscitation-promoting Factors Reveal an Occult Population of Tubercle Bacilli in Sputum
Mukamolova, G. V., Turapov, O., Malkin, J., Woltmann, G., & Barer, M. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0661oc · Cited by 280
A new method for estimating the effort required to control an infectious disease
Roberts, M. G., & Heesterbeek, J. A. P. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2003.2339 · Cited by 268
Global Epidemiology of Tuberculosis
Glaziou, P., Sismanidis, C., Floyd, K., & Raviglione, M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017798 · Cited by 252
Self-citationSonawane, A., Santos, J. C., Mishra, B. B., Jena, P., Progida, C., Sorensen, O. E., Gallo, R., Appelberg, R., & Griffiths, G. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01644.x · Cited by 165
Metadata
- Authors
- Dye, C., Williams, B. G., Espinal, M. A., & Raviglione, M. C.
- Venue
- Science
- Published
- 2002-03-15
- Volume
- 295
- Issue
- 5562
- Pages
- 2042-2046
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2092030365
- Cited by
- 314
- References
- 32
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.